HA 0.15%

· Taejoon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HA 0.15%, covering 2022-06-08 to 2022-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients [Phase 4]

See pricing